| Author | : Zhi-Ming Shao |
| File Size | : 50,8 Mb |
| Publisher | : Frontiers Media SA |
| Language | : English |
| Release Date | : 28 September 2022 |
| ISBN | : 9782832501016 |
| Pages | : 701 pages |
Download or read online Predictive Prognostic Biomarkers and Therapeutic Targets in Breast Cancer written by Zhi-Ming Shao,Yi-Zhou Jiang,Zhijie Jason Liu,Shengtao Zhou, published by Frontiers Media SA which was released on 2022-09-28. Get Predictive Prognostic Biomarkers and Therapeutic Targets in Breast Cancer Books now! Available in PDF,
Get BookDownload or read online Predictive Prognostic Biomarkers and Therapeutic Targets in Triple Negative Breast Cancer written by Shengtao Zhou,Zhi-Ming Shao,Zhijie Jason Liu,Yi-Zhou Jiang, published by Frontiers Media SA which was released on 2021-12-01. Get Predictive Prognostic Biomarkers and Therapeutic Targets in Triple Negative Breast Cancer Books
Get BookExpert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics
Get Book“Precision/personalized or stratified medicine” refers to the tailoring of medical treatment or drug administration to the individual characteristics of each patient treatment. It does not literally mean that a pharmaceutical company makes a drug for an individual patient for consumption and treatment but rather means the ability to stratify (
Get BookDownload or read online Advancements in Metastatic Breast Cancer Predictive and Prognostic Biomarkers and Molecular Mechanisms written by Masakazu Toi,San-Gang Wu, published by Frontiers Media SA which was released on 2022-09-27. Get Advancements in Metastatic Breast Cancer Predictive and Prognostic Biomarkers and Molecular Mechanisms Books now! Available in
Get BookBiomarkers are of critical medical importance for oncologists, allowing them to predict and detect disease and to determine the best course of action for cancer patient care. Prognostic markers are used to evaluate a patient’s outcome and cancer recurrence probability after initial interventions such as surgery or drug treatments
Get BookThis integrated book covers the entire spectrum of cancer biomarkers in development and clinical use. Predictive and prognostic markers are explored in the context of colon cancer, breast cancer, lung cancer, prostate cancer, and GIST. International experts provide insight into toxicity markers and surrogate markers. Attention is also given to
Get BookThe goal of personalized healthcare in the treatment of cancer is to reduce the attrition of novel oncology drugs and improve patient outcomes. The discovery and application of novel biomarkers is essential for the successful implementation of personalized healthcare for cancer patients. This chapter focuses on the types of biomarkers
Get Book